Showing results (131-140 of 141) with videos related to
Sort By:
Pageof 15
Circulation|October 1, 1993
Evaluation of ketanserin in the prevention of restenosis after percutaneous transluminal coronary angioplasty. A multicenter randomized double-blind placebo-controlled trialP W Serruys, W Klein, J P Tijssen, et al.Journal of Cardiovascular Pharmacology|January 1, 1993
Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study GroupW R Hermans, B J Rensing, D P Foley, et al.Journal of the American College of Cardiology|October 1, 1992
Therapeutic dissection after successful coronary balloon angioplasty: no influence on restenosis or on clinical outcome in 693 patients. The MERCATOR Study Group (Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis)W R Hermans, B J Rensing, D P Foley, et al.Ugeskrift for Laeger|November 11, 1996
[Angiopeptin versus placebo for reductin of restenosis after PTCA treatment. A randomized, double-blind study]U H Eriksen, O Amtorp, J P Bagger, et al.European Heart Journal|October 29, 2000
Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb study. GUSTO IIb InvestigatorsD K McGuire, H Emanuelsson, C B Granger, et al.European Heart Journal|February 22, 2000
Angiographical and Doppler flow-derived parameters for assessment of coronary lesion severity and its relation to the result of exercise electrocardiography. DEBATE study group. Doppler Endpoints Balloon Angioplasty Trial EuropeJ J Piek, E Boersma, C di Mario, et al.European Heart Journal|August 21, 2001
The immediate and long-term effect of optimal balloon angioplasty on the absolute coronary blood flow velocity reserve. A subanalysis of the DEBATE study. Doppler Endpoints Balloon Angioplasty Trial EuropeJ J Piek, E Boersma, M Voskuil, et al.Circulation|December 13, 1997
Prognostic value of intracoronary flow velocity and diameter stenosis in assessing the short- and long-term outcomes of coronary balloon angioplasty: the DEBATE Study (Doppler Endpoints Balloon Angioplasty Trial Europe)P W Serruys, C di Mario, J Piek, et al.Lancet (London, England)|September 5, 1998
Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)P W Serruys, B van Hout, H Bonnier, et al.Circulation|February 1, 1996
Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II Pilot StudyP W Serruys, H Emanuelsson, W van der Giessen, et al.Pageof 15